» Articles » PMID: 37147942

Placental Expression of Striatin & Endothelial Nitric Oxide Synthase in Women with & Without Pre-eclampsia

Overview
Specialty General Medicine
Date 2023 May 6
PMID 37147942
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Objectives: Striatin is a multi-domain scaffolding protein essential for activating endothelial nitric oxide synthase (eNOS). However, its role in pre-eclampsia remains use explored. Hence, this study aimed to investigate the association between striatin and eNOS in regulating nitric oxide (NO) production in the placenta of women with and without pre-eclampsia.

Methods: Forty pregnant women each without (controls) and with pre-eclampsia (cases) were enrolled in the study. Blood striatin and NO concentrations were detected by the ELISA. Protein expression of striatin, phosphorylated eNOS (peNOS), inducible NOS (iNOS) and phosphorylated NF-κB were measured in the placental tissues by Western blot. Twenty four hour urinary protein and serum urea, uric acid and creatinine were analyzed as an autoanalyzer. Placental histology was analyzed by haematoxylin and eosin staining. Results: Compared to normotensive pregnant women, the levels of serum NO and striatin were decreased in pre-eclamptic women. The protein expression of striatin and peNOS was significantly reduced (P<0.05) while p65NF-κB and iNOS were upregulated considerably (P<0.05) in the placenta of cases compared to controls.

Interpretation & Conclusions: Our results show for the first time that decreased striatin expression was associated with decreased peNOS protein expression in the placental tissue of pre-eclamptic women. Interestingly, no significant difference was found in blood striatin or NO levels between controls and cases. Thus, therapies that improve placental striatin expression are attractive possibilities, both for prevention as well as treatment of endothelial dysfunction in pre-eclampsia.

References
1.
Zhou C, Yan Q, Zou Q, Zhong X, Tyler C, Magness R . Sexual Dimorphisms of Preeclampsia-Dysregulated Transcriptomic Profiles and Cell Function in Fetal Endothelial Cells. Hypertension. 2019; 74(1):154-163. PMC: 6561818. DOI: 10.1161/HYPERTENSIONAHA.118.12569. View

2.
Thomson A, Telfer J, Kohnen G, Young A, Cameron I, Greer I . Nitric oxide synthase activity and localization do not change in uterus and placenta during human parturition. Hum Reprod. 1998; 12(11):2546-52. DOI: 10.1093/humrep/12.11.2546. View

3.
Morton A . Imitators of preeclampsia: A review. Pregnancy Hypertens. 2016; 6(1):1-9. DOI: 10.1016/j.preghy.2016.02.001. View

4.
Amaral L, Pinheiro L, Guimaraes D, Palei A, Sertorio J, Portella R . Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia. J Cell Mol Med. 2013; 17(10):1300-7. PMC: 4159028. DOI: 10.1111/jcmm.12106. View

5.
Armanini D, Zennaro C, Martella L, Scali M, Pratesi C, Grella P . Mineralocorticoid effector mechanism in preeclampsia. J Clin Endocrinol Metab. 1992; 74(4):946-9. DOI: 10.1210/jcem.74.4.1312543. View